Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
General Surgery | 22 | 2018 | 1693 | 1.360 |
Why?
|
Intestine, Small | 19 | 2015 | 1207 | 0.950 |
Why?
|
Surgical Procedures, Operative | 15 | 2017 | 1923 | 0.950 |
Why?
|
Jejunum | 40 | 2005 | 472 | 0.930 |
Why?
|
Intestinal Absorption | 30 | 2001 | 400 | 0.870 |
Why?
|
Intestinal Obstruction | 4 | 2015 | 432 | 0.640 |
Why?
|
Pancreatic Neoplasms | 29 | 2011 | 5366 | 0.630 |
Why?
|
Societies, Medical | 8 | 2020 | 3923 | 0.590 |
Why?
|
Substance P | 16 | 1989 | 334 | 0.560 |
Why?
|
Career Mobility | 2 | 2018 | 259 | 0.550 |
Why?
|
Ileum | 17 | 2005 | 557 | 0.530 |
Why?
|
Leadership | 4 | 2018 | 1385 | 0.490 |
Why?
|
Pancreatectomy | 6 | 2020 | 811 | 0.490 |
Why?
|
Electrolytes | 16 | 2001 | 274 | 0.490 |
Why?
|
Hospital Administration | 1 | 2018 | 352 | 0.480 |
Why?
|
Specialties, Surgical | 2 | 2017 | 389 | 0.480 |
Why?
|
Hospitals | 6 | 2016 | 3881 | 0.480 |
Why?
|
Biota | 1 | 2014 | 23 | 0.460 |
Why?
|
Serotonin | 18 | 1989 | 1042 | 0.440 |
Why?
|
Adenocarcinoma | 22 | 2008 | 6341 | 0.430 |
Why?
|
Cholecystectomy, Laparoscopic | 3 | 2013 | 231 | 0.420 |
Why?
|
Cost Savings | 3 | 2016 | 911 | 0.400 |
Why?
|
Personnel Staffing and Scheduling | 4 | 2006 | 495 | 0.390 |
Why?
|
Postoperative Complications | 18 | 2016 | 15637 | 0.370 |
Why?
|
Analgesia, Epidural | 1 | 2014 | 332 | 0.360 |
Why?
|
Mass Casualty Incidents | 1 | 2013 | 179 | 0.360 |
Why?
|
Regional Medical Programs | 1 | 2011 | 66 | 0.360 |
Why?
|
Dogs | 53 | 2001 | 3832 | 0.360 |
Why?
|
Hair | 1 | 2014 | 498 | 0.350 |
Why?
|
Quality Assurance, Health Care | 6 | 2016 | 2164 | 0.350 |
Why?
|
Clinical Competence | 7 | 2017 | 4788 | 0.350 |
Why?
|
Carrier State | 1 | 2014 | 522 | 0.350 |
Why?
|
Monosaccharide Transport Proteins | 8 | 2005 | 436 | 0.350 |
Why?
|
Internship and Residency | 11 | 2015 | 5885 | 0.340 |
Why?
|
Esophagectomy | 8 | 2011 | 469 | 0.330 |
Why?
|
Pancreatitis, Acute Necrotizing | 4 | 2009 | 171 | 0.320 |
Why?
|
Workload | 6 | 2011 | 845 | 0.310 |
Why?
|
Patient Admission | 2 | 2015 | 1365 | 0.310 |
Why?
|
Genes, p16 | 1 | 2008 | 160 | 0.310 |
Why?
|
Sleep Deprivation | 2 | 2013 | 847 | 0.310 |
Why?
|
Robotics | 2 | 2013 | 817 | 0.290 |
Why?
|
Surgical Sponges | 2 | 2009 | 39 | 0.290 |
Why?
|
Stress, Physiological | 4 | 2009 | 1405 | 0.290 |
Why?
|
Hysterectomy | 1 | 2013 | 857 | 0.290 |
Why?
|
Trauma Centers | 1 | 2013 | 938 | 0.290 |
Why?
|
Peptides | 18 | 2005 | 4353 | 0.290 |
Why?
|
Medical Errors | 7 | 2012 | 1263 | 0.290 |
Why?
|
Disaster Planning | 1 | 2013 | 557 | 0.280 |
Why?
|
Nesidioblastosis | 1 | 2006 | 4 | 0.280 |
Why?
|
Reimbursement Mechanisms | 1 | 2012 | 667 | 0.280 |
Why?
|
Gastrointestinal Hormones | 8 | 2004 | 101 | 0.280 |
Why?
|
Body Water | 8 | 1997 | 340 | 0.270 |
Why?
|
Intestinal Mucosa | 16 | 2005 | 3031 | 0.270 |
Why?
|
Bacterial Infections | 3 | 2014 | 1390 | 0.260 |
Why?
|
Work Schedule Tolerance | 4 | 2006 | 553 | 0.260 |
Why?
|
Surgery Department, Hospital | 2 | 2011 | 176 | 0.250 |
Why?
|
Referral and Consultation | 4 | 2014 | 3608 | 0.250 |
Why?
|
Infusions, Intra-Arterial | 2 | 2005 | 221 | 0.240 |
Why?
|
Chlorides | 14 | 1997 | 657 | 0.240 |
Why?
|
Medical Staff, Hospital | 4 | 2011 | 601 | 0.230 |
Why?
|
Cross-Cultural Comparison | 1 | 2007 | 634 | 0.230 |
Why?
|
Water | 18 | 1999 | 1410 | 0.230 |
Why?
|
Medicare | 5 | 2016 | 6773 | 0.230 |
Why?
|
Sodium | 19 | 2000 | 1589 | 0.230 |
Why?
|
Pancreatitis | 8 | 2005 | 1081 | 0.220 |
Why?
|
Health Personnel | 2 | 2016 | 3337 | 0.220 |
Why?
|
Varicose Veins | 1 | 2005 | 156 | 0.220 |
Why?
|
Surgical Wound Infection | 3 | 2016 | 1530 | 0.220 |
Why?
|
Hepatic Artery | 1 | 2005 | 232 | 0.220 |
Why?
|
Bariatric Surgery | 1 | 2014 | 991 | 0.220 |
Why?
|
Hyperinsulinism | 1 | 2006 | 400 | 0.220 |
Why?
|
Hyperglycemia | 2 | 2009 | 1375 | 0.210 |
Why?
|
Foreign Bodies | 2 | 2009 | 402 | 0.210 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2004 | 459 | 0.210 |
Why?
|
Pancreatic Diseases | 2 | 2020 | 345 | 0.210 |
Why?
|
Intraoperative Complications | 5 | 2012 | 1164 | 0.210 |
Why?
|
Quality Indicators, Health Care | 3 | 2017 | 1789 | 0.210 |
Why?
|
Deoxycytidine | 5 | 2004 | 878 | 0.210 |
Why?
|
Regional Blood Flow | 19 | 1986 | 1498 | 0.200 |
Why?
|
Physician Impairment | 1 | 2003 | 71 | 0.200 |
Why?
|
Hospitals, University | 2 | 2003 | 565 | 0.200 |
Why?
|
Verapamil | 3 | 1988 | 242 | 0.200 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1920 | 0.190 |
Why?
|
Wounds and Injuries | 2 | 2013 | 2493 | 0.190 |
Why?
|
Health Status Indicators | 1 | 2006 | 970 | 0.190 |
Why?
|
Humans | 143 | 2023 | 761208 | 0.190 |
Why?
|
United States | 28 | 2018 | 72339 | 0.190 |
Why?
|
Laparoscopy | 1 | 2013 | 2035 | 0.190 |
Why?
|
Peptic Ulcer | 3 | 1994 | 216 | 0.180 |
Why?
|
Islets of Langerhans | 4 | 1994 | 1342 | 0.180 |
Why?
|
Pancreatic Polypeptide | 3 | 1990 | 34 | 0.180 |
Why?
|
Stomach | 7 | 1990 | 697 | 0.180 |
Why?
|
Eating | 13 | 2001 | 1535 | 0.180 |
Why?
|
Health Care Costs | 1 | 2014 | 3239 | 0.180 |
Why?
|
Esophageal Neoplasms | 6 | 2011 | 1658 | 0.170 |
Why?
|
Surgical Instruments | 1 | 2003 | 383 | 0.170 |
Why?
|
Attitude of Health Personnel | 6 | 2015 | 3885 | 0.170 |
Why?
|
Cell Separation | 3 | 1994 | 1721 | 0.170 |
Why?
|
Macrophage Activation | 1 | 2003 | 552 | 0.170 |
Why?
|
Neoplasm, Residual | 1 | 2005 | 1008 | 0.170 |
Why?
|
Vascular Surgical Procedures | 5 | 2011 | 1489 | 0.170 |
Why?
|
Hypoglycemia | 1 | 2006 | 883 | 0.160 |
Why?
|
History, 20th Century | 3 | 2017 | 2765 | 0.160 |
Why?
|
Neuroendocrine Tumors | 1 | 2005 | 642 | 0.160 |
Why?
|
Norepinephrine | 7 | 1993 | 897 | 0.160 |
Why?
|
Health Policy | 4 | 2017 | 2679 | 0.160 |
Why?
|
Coronary Artery Bypass | 2 | 2007 | 2193 | 0.150 |
Why?
|
Hospitals, Teaching | 5 | 2012 | 1155 | 0.150 |
Why?
|
Pancreas | 7 | 2003 | 1684 | 0.150 |
Why?
|
Vagus Nerve | 8 | 2005 | 458 | 0.150 |
Why?
|
Operating Rooms | 3 | 2012 | 790 | 0.150 |
Why?
|
Gastric Bypass | 1 | 2006 | 818 | 0.150 |
Why?
|
Carcinoma, Papillary | 2 | 1995 | 785 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2014 | 10218 | 0.150 |
Why?
|
Stomach Ulcer | 5 | 1986 | 122 | 0.140 |
Why?
|
Female | 109 | 2023 | 392544 | 0.140 |
Why?
|
Hemodynamics | 9 | 1985 | 4165 | 0.140 |
Why?
|
Congresses as Topic | 2 | 2020 | 803 | 0.140 |
Why?
|
Infusions, Parenteral | 10 | 1986 | 398 | 0.140 |
Why?
|
Patient Readmission | 1 | 2011 | 3265 | 0.140 |
Why?
|
Academic Medical Centers | 7 | 2017 | 2756 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2004 | 2426 | 0.130 |
Why?
|
Ribonucleoside Diphosphate Reductase | 3 | 2004 | 31 | 0.130 |
Why?
|
Antimetabolites, Antineoplastic | 4 | 2004 | 646 | 0.130 |
Why?
|
Antacids | 2 | 1989 | 94 | 0.130 |
Why?
|
Lawyers | 1 | 2016 | 38 | 0.130 |
Why?
|
Male | 104 | 2016 | 360693 | 0.130 |
Why?
|
Animals | 112 | 2006 | 168079 | 0.130 |
Why?
|
Cell Adhesion Molecules | 4 | 2005 | 1603 | 0.120 |
Why?
|
Water-Electrolyte Balance | 5 | 1994 | 325 | 0.120 |
Why?
|
Survival Analysis | 11 | 2007 | 10088 | 0.120 |
Why?
|
Safety Management | 3 | 2011 | 761 | 0.120 |
Why?
|
Glucose | 6 | 2001 | 4342 | 0.120 |
Why?
|
Hepatic Duct, Common | 3 | 1992 | 48 | 0.120 |
Why?
|
History, 19th Century | 2 | 2009 | 718 | 0.120 |
Why?
|
Digestive System | 3 | 1985 | 244 | 0.120 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6919 | 0.120 |
Why?
|
Receptor, EphA2 | 2 | 2004 | 41 | 0.120 |
Why?
|
Delivery of Health Care | 4 | 2016 | 5333 | 0.110 |
Why?
|
Anoikis | 2 | 2004 | 50 | 0.110 |
Why?
|
Time Factors | 31 | 2013 | 39957 | 0.110 |
Why?
|
Lobbying | 1 | 2014 | 32 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 3 | 2014 | 571 | 0.110 |
Why?
|
Biological Transport | 10 | 2001 | 2080 | 0.110 |
Why?
|
Malpractice | 4 | 2007 | 553 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 983 | 0.110 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3691 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 3 | 2011 | 1228 | 0.110 |
Why?
|
Job Satisfaction | 2 | 2009 | 545 | 0.110 |
Why?
|
Adaptation, Physiological | 7 | 2005 | 1301 | 0.110 |
Why?
|
Glucagon-Like Peptides | 8 | 2005 | 153 | 0.110 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 1990 | 1116 | 0.110 |
Why?
|
Antigens, Neoplasm | 4 | 2005 | 1985 | 0.110 |
Why?
|
Occupations | 1 | 2016 | 517 | 0.110 |
Why?
|
src-Family Kinases | 3 | 2004 | 535 | 0.110 |
Why?
|
Rabbits | 12 | 1996 | 4750 | 0.110 |
Why?
|
Blood Glucose | 6 | 2009 | 6392 | 0.110 |
Why?
|
Homicide | 1 | 2016 | 294 | 0.110 |
Why?
|
Patient Identification Systems | 1 | 2013 | 75 | 0.110 |
Why?
|
Bombs | 1 | 2013 | 73 | 0.110 |
Why?
|
Perfusion | 11 | 1990 | 1390 | 0.100 |
Why?
|
Somatostatin | 2 | 1985 | 447 | 0.100 |
Why?
|
Boston | 6 | 2016 | 9327 | 0.100 |
Why?
|
Colectomy | 3 | 2006 | 686 | 0.100 |
Why?
|
Gastric Mucosa | 6 | 1998 | 603 | 0.100 |
Why?
|
Cell Division | 10 | 2004 | 4451 | 0.100 |
Why?
|
RNA Interference | 4 | 2004 | 2816 | 0.100 |
Why?
|
Anniversaries and Special Events | 1 | 2013 | 95 | 0.100 |
Why?
|
Feedback | 2 | 2015 | 790 | 0.100 |
Why?
|
Shock, Hemorrhagic | 6 | 1978 | 223 | 0.100 |
Why?
|
Models, Educational | 1 | 2015 | 373 | 0.100 |
Why?
|
Quality of Health Care | 3 | 2011 | 4320 | 0.100 |
Why?
|
Gastric Acid | 4 | 1990 | 99 | 0.100 |
Why?
|
Cholecystectomy | 5 | 2004 | 404 | 0.100 |
Why?
|
Gastrointestinal Motility | 6 | 1988 | 233 | 0.100 |
Why?
|
Isoproterenol | 5 | 1989 | 396 | 0.090 |
Why?
|
Obesity | 1 | 2014 | 12939 | 0.090 |
Why?
|
Anal Canal | 1 | 2014 | 374 | 0.090 |
Why?
|
Glucagon-Like Peptide 2 | 7 | 2005 | 45 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1852 | 0.090 |
Why?
|
Membrane Glycoproteins | 4 | 2004 | 3696 | 0.090 |
Why?
|
RNA, Small Interfering | 6 | 2004 | 3412 | 0.090 |
Why?
|
Patient Care | 1 | 2016 | 623 | 0.090 |
Why?
|
Critical Care | 4 | 2016 | 2696 | 0.090 |
Why?
|
Enkephalin, Methionine | 1 | 1990 | 26 | 0.090 |
Why?
|
Colon | 7 | 1997 | 1791 | 0.090 |
Why?
|
Health Care Reform | 2 | 2014 | 1247 | 0.090 |
Why?
|
Aged, 80 and over | 20 | 2015 | 58952 | 0.090 |
Why?
|
Naloxone | 2 | 1990 | 370 | 0.090 |
Why?
|
Survival Rate | 9 | 2013 | 12728 | 0.090 |
Why?
|
Polyarteritis Nodosa | 1 | 1991 | 70 | 0.090 |
Why?
|
Washington | 1 | 2011 | 314 | 0.090 |
Why?
|
Aged | 42 | 2016 | 169288 | 0.090 |
Why?
|
Middle Aged | 51 | 2016 | 220853 | 0.090 |
Why?
|
Liver Neoplasms | 3 | 2005 | 4309 | 0.090 |
Why?
|
Policy Making | 2 | 2011 | 541 | 0.090 |
Why?
|
Receptors, Opioid | 1 | 1990 | 145 | 0.080 |
Why?
|
Video Recording | 2 | 2012 | 965 | 0.080 |
Why?
|
Retrospective Studies | 26 | 2023 | 80674 | 0.080 |
Why?
|
Melanoma | 2 | 2023 | 5694 | 0.080 |
Why?
|
Education, Medical, Continuing | 2 | 2012 | 825 | 0.080 |
Why?
|
Sympathomimetics | 1 | 1989 | 57 | 0.080 |
Why?
|
Epinephrine | 4 | 1976 | 791 | 0.080 |
Why?
|
Pressure | 7 | 1990 | 1155 | 0.080 |
Why?
|
Gene Silencing | 3 | 2004 | 1495 | 0.080 |
Why?
|
Perineum | 2 | 2014 | 208 | 0.080 |
Why?
|
Cimetidine | 3 | 1988 | 76 | 0.080 |
Why?
|
Endorphins | 1 | 1989 | 74 | 0.080 |
Why?
|
Anti-Ulcer Agents | 1 | 1989 | 112 | 0.080 |
Why?
|
Legislation as Topic | 1 | 2009 | 76 | 0.080 |
Why?
|
SEER Program | 1 | 2014 | 1453 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 77 | 0.080 |
Why?
|
Physicians | 3 | 2016 | 4584 | 0.080 |
Why?
|
Benchmarking | 3 | 2016 | 1045 | 0.080 |
Why?
|
Hospitals, Community | 1 | 2011 | 365 | 0.080 |
Why?
|
Food | 7 | 2000 | 768 | 0.080 |
Why?
|
Students, Medical | 1 | 2002 | 1940 | 0.080 |
Why?
|
Communication | 5 | 2012 | 3872 | 0.080 |
Why?
|
History, 18th Century | 1 | 2009 | 206 | 0.080 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1988 | 146 | 0.080 |
Why?
|
Abdomen | 3 | 2005 | 1128 | 0.080 |
Why?
|
Tissue Donors | 3 | 1994 | 2335 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 15 | 2005 | 8164 | 0.070 |
Why?
|
Circadian Rhythm | 3 | 2005 | 2569 | 0.070 |
Why?
|
RNA, Messenger | 12 | 2005 | 12747 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2015 | 12052 | 0.070 |
Why?
|
Cytokines | 1 | 2003 | 7386 | 0.070 |
Why?
|
Intestines | 5 | 1996 | 1908 | 0.070 |
Why?
|
Endosonography | 2 | 2009 | 608 | 0.070 |
Why?
|
Ileostomy | 2 | 1999 | 121 | 0.070 |
Why?
|
Physician Incentive Plans | 1 | 2009 | 164 | 0.070 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1988 | 177 | 0.070 |
Why?
|
Malignant Carcinoid Syndrome | 2 | 1985 | 30 | 0.070 |
Why?
|
Rats | 21 | 2006 | 23704 | 0.070 |
Why?
|
Hospital Mortality | 3 | 2016 | 5295 | 0.070 |
Why?
|
Duodenal Neoplasms | 2 | 2003 | 114 | 0.070 |
Why?
|
Atrial Natriuretic Factor | 1 | 1988 | 350 | 0.070 |
Why?
|
Constriction, Pathologic | 3 | 2005 | 1097 | 0.070 |
Why?
|
Enteritis | 2 | 2000 | 162 | 0.070 |
Why?
|
Interprofessional Relations | 2 | 2012 | 990 | 0.070 |
Why?
|
Syndrome | 3 | 2008 | 3271 | 0.070 |
Why?
|
Mesenteric Veins | 2 | 2005 | 86 | 0.070 |
Why?
|
Codon | 1 | 2008 | 597 | 0.070 |
Why?
|
Rectal Neoplasms | 2 | 2014 | 1156 | 0.070 |
Why?
|
Neoplasm Invasiveness | 8 | 2004 | 3590 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2008 | 534 | 0.070 |
Why?
|
Teaching | 2 | 2012 | 1171 | 0.070 |
Why?
|
Venous Thrombosis | 2 | 2007 | 1304 | 0.070 |
Why?
|
Cats | 11 | 1988 | 974 | 0.070 |
Why?
|
Hospital Shared Services | 1 | 2006 | 16 | 0.070 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2005 | 1116 | 0.070 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 318 | 0.070 |
Why?
|
Peptide YY | 9 | 1997 | 135 | 0.070 |
Why?
|
Chewing Gum | 1 | 2006 | 40 | 0.070 |
Why?
|
Esophagoscopy | 1 | 1988 | 398 | 0.070 |
Why?
|
Prognosis | 12 | 2009 | 29687 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2015 | 1115 | 0.070 |
Why?
|
Blotting, Northern | 6 | 2005 | 1545 | 0.070 |
Why?
|
Ileus | 1 | 2006 | 66 | 0.070 |
Why?
|
Adult | 41 | 2014 | 221119 | 0.060 |
Why?
|
Esophagus | 2 | 1990 | 1036 | 0.060 |
Why?
|
Sodium-Glucose Transporter 1 | 5 | 2005 | 108 | 0.060 |
Why?
|
Blood Transfusion | 2 | 2006 | 1303 | 0.060 |
Why?
|
Mice, Nude | 7 | 2004 | 3605 | 0.060 |
Why?
|
Carcinoid Tumor | 2 | 2003 | 225 | 0.060 |
Why?
|
Catheterization | 3 | 2009 | 1428 | 0.060 |
Why?
|
Pancreatic Hormones | 1 | 1985 | 12 | 0.060 |
Why?
|
Germany | 1 | 2007 | 872 | 0.060 |
Why?
|
Cystadenocarcinoma | 1 | 2005 | 54 | 0.060 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 931 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 1994 | 1201 | 0.060 |
Why?
|
Urine | 1 | 2006 | 362 | 0.060 |
Why?
|
Blood Pressure | 12 | 2006 | 8479 | 0.060 |
Why?
|
Education, Medical, Graduate | 3 | 2005 | 2374 | 0.060 |
Why?
|
Education, Medical | 2 | 2009 | 1725 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7400 | 0.060 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2005 | 92 | 0.060 |
Why?
|
Cystadenoma | 1 | 2005 | 79 | 0.060 |
Why?
|
Treatment Outcome | 15 | 2013 | 64681 | 0.060 |
Why?
|
Cardia | 1 | 2004 | 60 | 0.060 |
Why?
|
Dinoprostone | 2 | 2004 | 597 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 1988 | 691 | 0.060 |
Why?
|
Drainage | 5 | 2009 | 1157 | 0.060 |
Why?
|
Safety | 2 | 2007 | 1151 | 0.060 |
Why?
|
Papio | 5 | 1978 | 669 | 0.060 |
Why?
|
Endotoxins | 2 | 1996 | 520 | 0.060 |
Why?
|
Keratins | 1 | 2006 | 498 | 0.060 |
Why?
|
Fluid Therapy | 2 | 2006 | 578 | 0.060 |
Why?
|
Multiple Organ Failure | 3 | 2009 | 386 | 0.060 |
Why?
|
Isoenzymes | 3 | 2004 | 1682 | 0.060 |
Why?
|
National Health Programs | 1 | 2007 | 440 | 0.060 |
Why?
|
Follow-Up Studies | 12 | 2011 | 39126 | 0.060 |
Why?
|
Muscle, Smooth | 2 | 2003 | 927 | 0.060 |
Why?
|
Professional Practice | 1 | 2006 | 313 | 0.060 |
Why?
|
Focal Adhesion Kinase 1 | 4 | 2004 | 120 | 0.060 |
Why?
|
Guanidines | 2 | 1982 | 194 | 0.060 |
Why?
|
Terminal Care | 1 | 2016 | 1760 | 0.060 |
Why?
|
Risk Adjustment | 1 | 2007 | 601 | 0.060 |
Why?
|
Politics | 1 | 2010 | 814 | 0.060 |
Why?
|
Comprehension | 1 | 2009 | 619 | 0.060 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 4 | 2004 | 185 | 0.050 |
Why?
|
Faculty, Medical | 1 | 2012 | 1205 | 0.050 |
Why?
|
Body Temperature | 1 | 2006 | 780 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2005 | 13632 | 0.050 |
Why?
|
Quality Improvement | 2 | 2016 | 3808 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 1990 | 2802 | 0.050 |
Why?
|
Neoplasm Transplantation | 5 | 2004 | 2010 | 0.050 |
Why?
|
Managed Care Programs | 1 | 2009 | 937 | 0.050 |
Why?
|
Physicians, Women | 1 | 2009 | 510 | 0.050 |
Why?
|
Haplorhini | 4 | 1978 | 523 | 0.050 |
Why?
|
Insulin | 5 | 1994 | 6588 | 0.050 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2003 | 145 | 0.050 |
Why?
|
Thyroid Hormones | 1 | 1986 | 402 | 0.050 |
Why?
|
Biometry | 1 | 2006 | 563 | 0.050 |
Why?
|
GPI-Linked Proteins | 4 | 2005 | 470 | 0.050 |
Why?
|
Exons | 1 | 2008 | 2380 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2006 | 637 | 0.050 |
Why?
|
History, 21st Century | 1 | 2009 | 1567 | 0.050 |
Why?
|
Patient Care Team | 3 | 2012 | 2515 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2011 | 15841 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2003 | 132 | 0.050 |
Why?
|
Learning | 1 | 2012 | 1737 | 0.050 |
Why?
|
Analysis of Variance | 5 | 2006 | 6223 | 0.050 |
Why?
|
Potassium | 7 | 1986 | 1309 | 0.050 |
Why?
|
Gallbladder Neoplasms | 1 | 2004 | 189 | 0.050 |
Why?
|
Gastrins | 4 | 1990 | 75 | 0.050 |
Why?
|
Neoplasm Seeding | 1 | 1982 | 84 | 0.050 |
Why?
|
Appendiceal Neoplasms | 1 | 2004 | 155 | 0.050 |
Why?
|
Gastric Emptying | 2 | 1996 | 243 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2009 | 3627 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2001 | 75 | 0.050 |
Why?
|
Continuity of Patient Care | 2 | 2012 | 1069 | 0.050 |
Why?
|
Acute Disease | 9 | 2009 | 7226 | 0.050 |
Why?
|
Bile Duct Diseases | 2 | 1992 | 97 | 0.050 |
Why?
|
Ischemia | 5 | 1993 | 1889 | 0.050 |
Why?
|
Emotions | 1 | 2013 | 2742 | 0.050 |
Why?
|
Rhabdomyosarcoma | 1 | 2004 | 358 | 0.050 |
Why?
|
Ion Channels | 1 | 1986 | 1038 | 0.050 |
Why?
|
Gene Targeting | 1 | 2004 | 838 | 0.050 |
Why?
|
Intestinal Neoplasms | 1 | 2003 | 315 | 0.050 |
Why?
|
Microfluidics | 1 | 2006 | 651 | 0.050 |
Why?
|
Anus Neoplasms | 1 | 2005 | 330 | 0.050 |
Why?
|
Massachusetts | 4 | 2016 | 8837 | 0.050 |
Why?
|
Liver Circulation | 4 | 1987 | 159 | 0.050 |
Why?
|
Caspases | 4 | 2004 | 878 | 0.050 |
Why?
|
Thromboembolism | 1 | 2007 | 992 | 0.040 |
Why?
|
Microspheres | 10 | 1986 | 783 | 0.040 |
Why?
|
Cell Line, Tumor | 10 | 2004 | 16952 | 0.040 |
Why?
|
Vascular Resistance | 4 | 1988 | 933 | 0.040 |
Why?
|
Physical Examination | 1 | 2006 | 1255 | 0.040 |
Why?
|
New York | 1 | 2003 | 875 | 0.040 |
Why?
|
Fibronectins | 1 | 2004 | 724 | 0.040 |
Why?
|
Incidence | 6 | 2009 | 21365 | 0.040 |
Why?
|
Curriculum | 1 | 2014 | 3741 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2008 | 1852 | 0.040 |
Why?
|
Quality of Life | 3 | 2016 | 13367 | 0.040 |
Why?
|
Accreditation | 1 | 2003 | 473 | 0.040 |
Why?
|
Absorption | 4 | 1999 | 242 | 0.040 |
Why?
|
Reoperation | 4 | 2003 | 4303 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2006 | 1472 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2004 | 732 | 0.040 |
Why?
|
Stomach Neoplasms | 2 | 2004 | 1457 | 0.040 |
Why?
|
Utah | 2 | 2016 | 130 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 1982 | 433 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 1982 | 426 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2004 | 10756 | 0.040 |
Why?
|
Atropine | 6 | 1990 | 244 | 0.040 |
Why?
|
Odds Ratio | 3 | 2011 | 9652 | 0.040 |
Why?
|
Risk Factors | 11 | 2016 | 74239 | 0.040 |
Why?
|
Tumor Cells, Cultured | 5 | 2004 | 6124 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 2005 | 791 | 0.040 |
Why?
|
Hepatocytes | 1 | 2006 | 1231 | 0.040 |
Why?
|
Blood Circulation | 2 | 1977 | 248 | 0.040 |
Why?
|
Thyroid Gland | 1 | 1986 | 1169 | 0.040 |
Why?
|
Amiloride | 2 | 1996 | 116 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2007 | 1401 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 3 | 1998 | 476 | 0.040 |
Why?
|
Models, Economic | 2 | 2016 | 714 | 0.040 |
Why?
|
Emergency Treatment | 1 | 2003 | 495 | 0.040 |
Why?
|
Islets of Langerhans Transplantation | 2 | 1994 | 743 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 4 | 2009 | 20588 | 0.040 |
Why?
|
Ferricyanides | 1 | 1978 | 31 | 0.040 |
Why?
|
Endoscopy, Digestive System | 1 | 2001 | 353 | 0.040 |
Why?
|
Cardiac Output | 5 | 1984 | 831 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2009 | 2004 | 0.040 |
Why?
|
Prospective Studies | 9 | 2009 | 54435 | 0.040 |
Why?
|
Enzyme Inhibitors | 3 | 2003 | 3702 | 0.040 |
Why?
|
Fistula | 3 | 1996 | 212 | 0.040 |
Why?
|
Growth Hormone | 1 | 2001 | 569 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2001 | 699 | 0.040 |
Why?
|
Sympathetic Nervous System | 2 | 1985 | 519 | 0.040 |
Why?
|
Hormones | 1 | 1982 | 868 | 0.040 |
Why?
|
Florida | 1 | 2020 | 429 | 0.040 |
Why?
|
Malabsorption Syndromes | 2 | 1996 | 135 | 0.040 |
Why?
|
Nitroprusside | 1 | 1978 | 272 | 0.040 |
Why?
|
Phenylephrine | 2 | 1989 | 294 | 0.040 |
Why?
|
Insurance Claim Review | 2 | 2016 | 741 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2005 | 11856 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 2003 | 554 | 0.040 |
Why?
|
Clonidine | 2 | 1989 | 168 | 0.040 |
Why?
|
Research | 3 | 1995 | 1976 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2003 | 1200 | 0.040 |
Why?
|
Aquaporins | 1 | 1999 | 174 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 15721 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2004 | 4513 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20982 | 0.040 |
Why?
|
Oxygen | 4 | 2006 | 4227 | 0.040 |
Why?
|
Receptors, Gastrointestinal Hormone | 1 | 1997 | 39 | 0.040 |
Why?
|
Sex Distribution | 2 | 2016 | 2277 | 0.040 |
Why?
|
Delphi Technique | 1 | 2021 | 848 | 0.040 |
Why?
|
Phlorhizin | 3 | 2001 | 37 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1990 | 3366 | 0.040 |
Why?
|
Short Bowel Syndrome | 1 | 2001 | 353 | 0.040 |
Why?
|
Portal System | 2 | 1988 | 49 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 6 | 1989 | 2477 | 0.030 |
Why?
|
Ultrasonography | 1 | 1990 | 5969 | 0.030 |
Why?
|
Oligopeptides | 1 | 1982 | 1179 | 0.030 |
Why?
|
Arteriovenous Anastomosis | 1 | 1976 | 14 | 0.030 |
Why?
|
Menopause | 1 | 2005 | 1646 | 0.030 |
Why?
|
Pancreatic Pseudocyst | 2 | 1990 | 111 | 0.030 |
Why?
|
Antibodies | 1 | 2005 | 2415 | 0.030 |
Why?
|
Gastrectomy | 3 | 2004 | 671 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1895 | 0.030 |
Why?
|
Glucose Tolerance Test | 2 | 1990 | 1178 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2004 | 1933 | 0.030 |
Why?
|
Evaluation Studies as Topic | 4 | 2012 | 1624 | 0.030 |
Why?
|
Insurance, Health | 1 | 2009 | 2493 | 0.030 |
Why?
|
Logistic Models | 3 | 2009 | 13249 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2005 | 2220 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2004 | 4909 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 1998 | 287 | 0.030 |
Why?
|
Vermont | 1 | 2016 | 81 | 0.030 |
Why?
|
Cause of Death | 1 | 2006 | 3688 | 0.030 |
Why?
|
Data Collection | 3 | 2015 | 3320 | 0.030 |
Why?
|
Nitric Oxide | 2 | 1996 | 2136 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2008 | 3025 | 0.030 |
Why?
|
Episode of Care | 1 | 2016 | 128 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3726 | 0.030 |
Why?
|
Heart Diseases | 1 | 2009 | 2795 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 999 | 0.030 |
Why?
|
Cholecystokinin | 1 | 1996 | 115 | 0.030 |
Why?
|
Glucose Transporter Type 5 | 2 | 2005 | 12 | 0.030 |
Why?
|
Adrenergic Agonists | 1 | 1975 | 57 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 26071 | 0.030 |
Why?
|
Genetic Testing | 1 | 2008 | 3537 | 0.030 |
Why?
|
Peptide Biosynthesis | 1 | 1995 | 52 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2006 | 1277 | 0.030 |
Why?
|
Glucose Transporter Type 2 | 2 | 2005 | 61 | 0.030 |
Why?
|
Thrombophlebitis | 1 | 1976 | 289 | 0.030 |
Why?
|
Primates | 1 | 1978 | 521 | 0.030 |
Why?
|
Fluorouracil | 1 | 2000 | 1642 | 0.030 |
Why?
|
Capitation Fee | 1 | 1995 | 115 | 0.030 |
Why?
|
Michigan | 1 | 2016 | 339 | 0.030 |
Why?
|
Injections, Intravenous | 3 | 1992 | 1376 | 0.030 |
Why?
|
Heart Rate | 1 | 2006 | 4197 | 0.030 |
Why?
|
Vasopressins | 1 | 1976 | 351 | 0.030 |
Why?
|
Bile Ducts | 2 | 1993 | 284 | 0.030 |
Why?
|
Hindlimb | 2 | 1996 | 513 | 0.030 |
Why?
|
Sodium Channel Blockers | 1 | 1996 | 172 | 0.030 |
Why?
|
Osmolar Concentration | 3 | 2000 | 659 | 0.030 |
Why?
|
Gene Expression | 3 | 2004 | 7571 | 0.030 |
Why?
|
Vasodilation | 2 | 1996 | 966 | 0.030 |
Why?
|
Acids | 1 | 1975 | 124 | 0.030 |
Why?
|
Centrifugation, Zonal | 1 | 1994 | 14 | 0.030 |
Why?
|
Program Evaluation | 2 | 2015 | 2489 | 0.030 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 1996 | 359 | 0.030 |
Why?
|
Cholelithiasis | 4 | 2003 | 407 | 0.030 |
Why?
|
Triage | 1 | 2021 | 985 | 0.030 |
Why?
|
Rehydration Solutions | 1 | 1994 | 43 | 0.030 |
Why?
|
Mixed Tumor, Malignant | 1 | 1994 | 16 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2009 | 14675 | 0.030 |
Why?
|
Postoperative Period | 4 | 2008 | 1818 | 0.030 |
Why?
|
Enzyme Induction | 2 | 2004 | 452 | 0.030 |
Why?
|
Intestinal Fistula | 4 | 2000 | 142 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2014 | 11119 | 0.030 |
Why?
|
Antigens, CD | 4 | 2005 | 4009 | 0.030 |
Why?
|
Body Mass Index | 3 | 2005 | 12952 | 0.030 |
Why?
|
Fetal Tissue Transplantation | 1 | 1994 | 138 | 0.030 |
Why?
|
Hyperemia | 2 | 1986 | 225 | 0.030 |
Why?
|
Arteries | 2 | 1975 | 1121 | 0.030 |
Why?
|
Collagenases | 1 | 1994 | 222 | 0.030 |
Why?
|
Calcium | 2 | 1986 | 5719 | 0.030 |
Why?
|
Culture Techniques | 1 | 1994 | 531 | 0.030 |
Why?
|
Gastrinoma | 2 | 1990 | 20 | 0.030 |
Why?
|
Renal Circulation | 2 | 1985 | 291 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2014 | 301 | 0.030 |
Why?
|
Random Allocation | 4 | 2005 | 2393 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10707 | 0.030 |
Why?
|
Energy Intake | 2 | 1993 | 2133 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 1994 | 453 | 0.030 |
Why?
|
Biliary Fistula | 1 | 1993 | 37 | 0.030 |
Why?
|
Pancreatic Fistula | 1 | 1974 | 148 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15308 | 0.030 |
Why?
|
Down-Regulation | 1 | 2000 | 2916 | 0.030 |
Why?
|
Haiti | 1 | 2015 | 549 | 0.030 |
Why?
|
Carcinosarcoma | 1 | 1994 | 106 | 0.030 |
Why?
|
Pancreatic Cyst | 2 | 1990 | 367 | 0.030 |
Why?
|
Signal Transduction | 4 | 2005 | 23416 | 0.030 |
Why?
|
Skin Neoplasms | 2 | 2004 | 5809 | 0.030 |
Why?
|
Cadaver | 2 | 1994 | 1358 | 0.030 |
Why?
|
Pyrazoles | 1 | 2003 | 2010 | 0.030 |
Why?
|
Databases, Factual | 3 | 2016 | 7966 | 0.030 |
Why?
|
Rwanda | 1 | 2015 | 660 | 0.030 |
Why?
|
Health Maintenance Organizations | 1 | 1995 | 658 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2006 | 3418 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2527 | 0.030 |
Why?
|
Cohort Studies | 4 | 2009 | 41496 | 0.030 |
Why?
|
Models, Statistical | 1 | 2007 | 5081 | 0.030 |
Why?
|
Sarcoma | 1 | 2003 | 1800 | 0.030 |
Why?
|
Ion Transport | 3 | 1999 | 319 | 0.030 |
Why?
|
Blotting, Western | 3 | 2004 | 5032 | 0.030 |
Why?
|
Reperfusion | 1 | 1993 | 271 | 0.030 |
Why?
|
Clinical Trials as Topic | 3 | 2005 | 8003 | 0.020 |
Why?
|
Lactones | 2 | 2004 | 316 | 0.020 |
Why?
|
Cyclooxygenase 2 | 2 | 2004 | 597 | 0.020 |
Why?
|
Peer Review, Research | 1 | 2015 | 339 | 0.020 |
Why?
|
Caco-2 Cells | 2 | 2004 | 363 | 0.020 |
Why?
|
Cost Control | 1 | 2014 | 627 | 0.020 |
Why?
|
Sulfones | 2 | 2004 | 448 | 0.020 |
Why?
|
Deoxyglucose | 1 | 1992 | 333 | 0.020 |
Why?
|
Risk Assessment | 4 | 2011 | 24021 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3134 | 0.020 |
Why?
|
Pyridines | 1 | 2003 | 2872 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2001 | 6304 | 0.020 |
Why?
|
Fee-for-Service Plans | 1 | 2016 | 698 | 0.020 |
Why?
|
Amylases | 2 | 1989 | 171 | 0.020 |
Why?
|
Apoptosis | 5 | 2004 | 9477 | 0.020 |
Why?
|
Wound Healing | 1 | 2002 | 2800 | 0.020 |
Why?
|
Electric Stimulation | 6 | 1988 | 1736 | 0.020 |
Why?
|
Propranolol | 5 | 1988 | 490 | 0.020 |
Why?
|
Fever | 1 | 1978 | 1618 | 0.020 |
Why?
|
Bombesin | 1 | 1990 | 35 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2015 | 697 | 0.020 |
Why?
|
Liver | 1 | 2006 | 7514 | 0.020 |
Why?
|
Hydrochloric Acid | 2 | 2002 | 76 | 0.020 |
Why?
|
Adenoma, Bile Duct | 1 | 1990 | 29 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2008 | 5666 | 0.020 |
Why?
|
Informed Consent | 1 | 2017 | 1008 | 0.020 |
Why?
|
Adenoma, Islet Cell | 1 | 1990 | 72 | 0.020 |
Why?
|
Magnesium Hydroxide | 1 | 1989 | 9 | 0.020 |
Why?
|
Permeability | 3 | 1996 | 721 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2005 | 2421 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 1994 | 664 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2002 | 3671 | 0.020 |
Why?
|
Tetrodotoxin | 3 | 1990 | 245 | 0.020 |
Why?
|
Cell Survival | 2 | 2004 | 5778 | 0.020 |
Why?
|
Kidney | 2 | 1985 | 7033 | 0.020 |
Why?
|
Learning Curve | 1 | 2012 | 230 | 0.020 |
Why?
|
Alprostadil | 1 | 1989 | 86 | 0.020 |
Why?
|
Aluminum Hydroxide | 1 | 1989 | 54 | 0.020 |
Why?
|
Consciousness | 2 | 1986 | 601 | 0.020 |
Why?
|
Mannitol | 3 | 1999 | 177 | 0.020 |
Why?
|
Phorbol Esters | 1 | 1989 | 108 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 59221 | 0.020 |
Why?
|
Neurons, Afferent | 1 | 1992 | 498 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2016 | 801 | 0.020 |
Why?
|
Mentors | 1 | 2015 | 663 | 0.020 |
Why?
|
Vasodilator Agents | 4 | 1996 | 989 | 0.020 |
Why?
|
Enterochromaffin Cells | 3 | 1986 | 12 | 0.020 |
Why?
|
Membrane Proteins | 3 | 2004 | 7851 | 0.020 |
Why?
|
Rats, Inbred Strains | 2 | 1992 | 2087 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 1992 | 1123 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1990 | 293 | 0.020 |
Why?
|
Quality Control | 1 | 2012 | 833 | 0.020 |
Why?
|
Nerve Block | 3 | 1994 | 706 | 0.020 |
Why?
|
Thymus Gland | 1 | 1994 | 1243 | 0.020 |
Why?
|
Esophagostomy | 1 | 1988 | 6 | 0.020 |
Why?
|
Esophagoscopes | 1 | 1988 | 16 | 0.020 |
Why?
|
Professional Competence | 1 | 2012 | 430 | 0.020 |
Why?
|
Misoprostol | 1 | 1989 | 93 | 0.020 |
Why?
|
Rats, Inbred Lew | 3 | 1995 | 1159 | 0.020 |
Why?
|
Pentagastrin | 2 | 1985 | 17 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1423 | 0.020 |
Why?
|
Amino Acids | 1 | 1995 | 1703 | 0.020 |
Why?
|
Problem-Based Learning | 1 | 2012 | 356 | 0.020 |
Why?
|
Biopsy | 2 | 1998 | 6781 | 0.020 |
Why?
|
Up-Regulation | 3 | 2004 | 4111 | 0.020 |
Why?
|
Penicillin V | 1 | 1968 | 18 | 0.020 |
Why?
|
Penicillium | 1 | 1968 | 22 | 0.020 |
Why?
|
Penicillin G | 1 | 1968 | 40 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2510 | 0.020 |
Why?
|
Glycolates | 1 | 1968 | 40 | 0.020 |
Why?
|
Parenteral Nutrition, Total | 1 | 1989 | 304 | 0.020 |
Why?
|
Phenylacetates | 1 | 1968 | 111 | 0.020 |
Why?
|
Transcription Factors | 2 | 2004 | 12099 | 0.020 |
Why?
|
Chronic Disease | 4 | 1993 | 9319 | 0.020 |
Why?
|
Metiamide | 2 | 1977 | 6 | 0.020 |
Why?
|
Emergencies | 2 | 1992 | 1217 | 0.020 |
Why?
|
Marriage | 1 | 2009 | 349 | 0.020 |
Why?
|
Recurrence | 2 | 2009 | 8457 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 695 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5250 | 0.020 |
Why?
|
Gastric Acidity Determination | 3 | 1977 | 56 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2009 | 393 | 0.020 |
Why?
|
Probability | 2 | 2009 | 2478 | 0.020 |
Why?
|
Anastomosis, Surgical | 2 | 2005 | 982 | 0.020 |
Why?
|
Thiourea | 2 | 1977 | 68 | 0.020 |
Why?
|
Cholangitis | 1 | 1988 | 109 | 0.020 |
Why?
|
Mice | 8 | 2006 | 81326 | 0.020 |
Why?
|
Electrophysiology | 2 | 2002 | 1262 | 0.020 |
Why?
|
Phenoxybenzamine | 3 | 1988 | 53 | 0.020 |
Why?
|
Biological Transport, Active | 2 | 1979 | 323 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17897 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 1978 | 325 | 0.020 |
Why?
|
Pilot Projects | 2 | 2012 | 8642 | 0.020 |
Why?
|
Tetragastrin | 2 | 1985 | 4 | 0.020 |
Why?
|
Endothelium, Vascular | 2 | 1996 | 4420 | 0.020 |
Why?
|
Taurocholic Acid | 2 | 1977 | 43 | 0.020 |
Why?
|
Hospitals, General | 1 | 2011 | 799 | 0.020 |
Why?
|
Duodenum | 3 | 1990 | 491 | 0.020 |
Why?
|
Keratin-20 | 1 | 2006 | 31 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3777 | 0.020 |
Why?
|
Keratin-7 | 1 | 2006 | 55 | 0.020 |
Why?
|
Lymphatic Metastasis | 3 | 2004 | 2913 | 0.020 |
Why?
|
Disease Models, Animal | 6 | 2005 | 18220 | 0.020 |
Why?
|
Contrast Media | 2 | 2009 | 5311 | 0.020 |
Why?
|
Isotonic Solutions | 2 | 1996 | 117 | 0.020 |
Why?
|
Vagotomy, Truncal | 1 | 2005 | 9 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2004 | 2381 | 0.020 |
Why?
|
Sucrase | 1 | 2005 | 51 | 0.020 |
Why?
|
Forecasting | 2 | 2005 | 2928 | 0.020 |
Why?
|
Efficiency | 1 | 2009 | 476 | 0.020 |
Why?
|
Occupational Health | 1 | 2012 | 807 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1990 | 592 | 0.020 |
Why?
|
Gastrostomy | 1 | 1988 | 323 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2004 | 12976 | 0.020 |
Why?
|
Gastric Juice | 2 | 1975 | 59 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2001 | 7407 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2928 | 0.020 |
Why?
|
Skin Diseases | 1 | 1974 | 1095 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1986 | 413 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2004 | 2455 | 0.020 |
Why?
|
Femoral Artery | 3 | 1993 | 826 | 0.020 |
Why?
|
Dideoxyadenosine | 1 | 2004 | 9 | 0.020 |
Why?
|
Kidney Cortex | 1 | 1985 | 168 | 0.020 |
Why?
|
Parasympathetic Nervous System | 1 | 1985 | 143 | 0.020 |
Why?
|
Ephrin-A1 | 1 | 2004 | 9 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2003 | 22174 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1998 | 4935 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 2007 | 395 | 0.010 |
Why?
|
Rosaniline Dyes | 1 | 2004 | 50 | 0.010 |
Why?
|
Suicide | 1 | 2016 | 1602 | 0.010 |
Why?
|
Kidney Medulla | 1 | 1985 | 169 | 0.010 |
Why?
|
3T3 Cells | 1 | 2006 | 1083 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 2004 | 176 | 0.010 |
Why?
|
Sepsis | 2 | 1976 | 2585 | 0.010 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2004 | 63 | 0.010 |
Why?
|
Information Services | 1 | 2006 | 236 | 0.010 |
Why?
|
Penicillins | 1 | 1968 | 403 | 0.010 |
Why?
|
Digestion | 2 | 1996 | 53 | 0.010 |
Why?
|
Sigmoid Neoplasms | 1 | 2004 | 53 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1989 | 1702 | 0.010 |
Why?
|
Serotonin Antagonists | 1 | 1985 | 144 | 0.010 |
Why?
|
Mortality | 1 | 2016 | 2896 | 0.010 |
Why?
|
DNA | 3 | 2004 | 7189 | 0.010 |
Why?
|
Receptors, Glucagon | 1 | 2004 | 90 | 0.010 |
Why?
|
Receptor, EphB3 | 1 | 2003 | 11 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2004 | 18926 | 0.010 |
Why?
|
Triiodothyronine | 1 | 1986 | 492 | 0.010 |
Why?
|
Bile Duct Neoplasms | 1 | 1990 | 607 | 0.010 |
Why?
|
Pneumonia | 1 | 2016 | 2142 | 0.010 |
Why?
|
Glucose Transporter Type 1 | 1 | 2004 | 185 | 0.010 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 2004 | 74 | 0.010 |
Why?
|
Endopeptidases | 2 | 1978 | 766 | 0.010 |
Why?
|
Private Sector | 1 | 2007 | 394 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2004 | 8530 | 0.010 |
Why?
|
Los Angeles | 2 | 1996 | 244 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2007 | 1046 | 0.010 |
Why?
|
Hexamethonium Compounds | 3 | 1988 | 23 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2854 | 0.010 |
Why?
|
Oncogene Protein v-akt | 1 | 2004 | 129 | 0.010 |
Why?
|
Heart Arrest | 1 | 1994 | 1513 | 0.010 |
Why?
|
Quinones | 1 | 2003 | 78 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3422 | 0.010 |
Why?
|
E2F1 Transcription Factor | 1 | 2004 | 178 | 0.010 |
Why?
|
Genistein | 1 | 2003 | 86 | 0.010 |
Why?
|
Rifabutin | 1 | 2003 | 59 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2011 | 2425 | 0.010 |
Why?
|
Peristalsis | 1 | 1983 | 60 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2004 | 269 | 0.010 |
Why?
|
Brunner Glands | 1 | 2003 | 11 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2004 | 314 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2004 | 573 | 0.010 |
Why?
|
Morbidity | 2 | 2000 | 1751 | 0.010 |
Why?
|
Drug Combinations | 1 | 1989 | 2048 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8663 | 0.010 |
Why?
|
Radioimmunoassay | 3 | 1994 | 862 | 0.010 |
Why?
|
Capsaicin | 2 | 1996 | 232 | 0.010 |
Why?
|
Common Bile Duct Diseases | 1 | 1983 | 36 | 0.010 |
Why?
|
Urodynamics | 1 | 1985 | 346 | 0.010 |
Why?
|
Cholestasis, Extrahepatic | 1 | 1983 | 52 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2004 | 464 | 0.010 |
Why?
|
Benzoquinones | 1 | 2003 | 198 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2004 | 282 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 2 | 1996 | 4021 | 0.010 |
Why?
|
Methods | 3 | 1990 | 1063 | 0.010 |
Why?
|
Intestinal Polyps | 1 | 2003 | 105 | 0.010 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7804 | 0.010 |
Why?
|
Staff Development | 1 | 2005 | 227 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2004 | 2864 | 0.010 |
Why?
|
Jejunostomy | 2 | 1994 | 59 | 0.010 |
Why?
|
Acetylcholine | 2 | 1996 | 629 | 0.010 |
Why?
|
Macaca mulatta | 3 | 1985 | 2328 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2006 | 538 | 0.010 |
Why?
|
Laminin | 1 | 2004 | 407 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2871 | 0.010 |
Why?
|
Ganglia, Sympathetic | 2 | 1996 | 65 | 0.010 |
Why?
|
Phosphorylation | 2 | 2004 | 8300 | 0.010 |
Why?
|
Luciferases | 1 | 2004 | 710 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2004 | 282 | 0.010 |
Why?
|
Cell Movement | 2 | 2004 | 5195 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2004 | 628 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2006 | 1334 | 0.010 |
Why?
|
Comorbidity | 2 | 2014 | 10516 | 0.010 |
Why?
|
Thymidine | 1 | 2002 | 296 | 0.010 |
Why?
|
Administration, Oral | 1 | 1990 | 4015 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2004 | 321 | 0.010 |
Why?
|
Chromaffin System | 1 | 1981 | 15 | 0.010 |
Why?
|
Blood Flow Velocity | 2 | 1976 | 1375 | 0.010 |
Why?
|
Cholecystitis | 2 | 1993 | 180 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 2004 | 380 | 0.010 |
Why?
|
Coloring Agents | 1 | 2004 | 561 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 614 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 2003 | 318 | 0.010 |
Why?
|
Cholera Toxin | 1 | 2004 | 559 | 0.010 |
Why?
|
Cachexia | 1 | 2003 | 202 | 0.010 |
Why?
|
Retroviridae | 1 | 2004 | 850 | 0.010 |
Why?
|
Microcirculation | 2 | 1978 | 1280 | 0.010 |
Why?
|
Tritium | 1 | 2002 | 706 | 0.010 |
Why?
|
Skin | 2 | 1990 | 4473 | 0.010 |
Why?
|
Androstadienes | 1 | 2003 | 348 | 0.010 |
Why?
|
Ghrelin | 1 | 2003 | 251 | 0.010 |
Why?
|
Placebos | 1 | 2006 | 1666 | 0.010 |
Why?
|
Risk | 2 | 1986 | 9616 | 0.010 |
Why?
|
Pyrimidines | 2 | 2004 | 3027 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 2 | 1986 | 174 | 0.010 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2003 | 219 | 0.010 |
Why?
|
3-O-Methylglucose | 1 | 2001 | 37 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2004 | 850 | 0.010 |
Why?
|
Bile | 1 | 1982 | 297 | 0.010 |
Why?
|
Guanosine | 1 | 2001 | 43 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2004 | 631 | 0.010 |
Why?
|
Radiography | 3 | 2009 | 6974 | 0.010 |
Why?
|
Hypothyroidism | 1 | 1986 | 668 | 0.010 |
Why?
|
Adolescent | 7 | 2008 | 88298 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1577 | 0.010 |
Why?
|
Injections | 2 | 1996 | 832 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2004 | 1462 | 0.010 |
Why?
|
Kinetics | 2 | 2001 | 6312 | 0.010 |
Why?
|
Lidocaine | 1 | 1983 | 538 | 0.010 |
Why?
|
Thyroidectomy | 1 | 1986 | 908 | 0.010 |
Why?
|
Electric Conductivity | 1 | 2001 | 405 | 0.010 |
Why?
|
Cell Count | 1 | 2004 | 1831 | 0.010 |
Why?
|
Enteral Nutrition | 2 | 1997 | 794 | 0.010 |
Why?
|
Cell Membrane Permeability | 2 | 1999 | 573 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 2000 | 310 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1982 | 552 | 0.010 |
Why?
|
Patient Transfer | 1 | 2007 | 794 | 0.010 |
Why?
|
Phenols | 1 | 2003 | 517 | 0.010 |
Why?
|
Cholestasis | 1 | 1983 | 378 | 0.010 |
Why?
|
Drug Synergism | 1 | 2004 | 1756 | 0.010 |
Why?
|
Tyrosine | 1 | 2004 | 1422 | 0.010 |
Why?
|
Inpatients | 1 | 2011 | 2545 | 0.010 |
Why?
|
Infusions, Intravenous | 2 | 1996 | 2217 | 0.010 |
Why?
|
Biomedical Research | 1 | 2015 | 3434 | 0.010 |
Why?
|
Aquaporin 3 | 1 | 1999 | 14 | 0.010 |
Why?
|
Colorado | 1 | 1999 | 165 | 0.010 |
Why?
|
Base Sequence | 3 | 1995 | 12404 | 0.010 |
Why?
|
Maltose | 1 | 1999 | 39 | 0.010 |
Why?
|
Renal Artery | 1 | 1980 | 351 | 0.010 |
Why?
|
Cell Line | 2 | 2004 | 15545 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2004 | 5300 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6486 | 0.010 |
Why?
|
Models, Biological | 2 | 1986 | 9457 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 471 | 0.010 |
Why?
|
Light | 1 | 2004 | 1348 | 0.010 |
Why?
|
Aspirin | 2 | 2004 | 3129 | 0.010 |
Why?
|
Family | 1 | 2009 | 3192 | 0.010 |
Why?
|
H(+)-K(+)-Exchanging ATPase | 1 | 1998 | 36 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1749 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 475 | 0.010 |
Why?
|
Carbon Dioxide | 3 | 1978 | 1147 | 0.010 |
Why?
|
Macaca fascicularis | 2 | 1978 | 901 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 1978 | 178 | 0.010 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 1998 | 106 | 0.010 |
Why?
|
Electric Impedance | 1 | 2002 | 756 | 0.010 |
Why?
|
Prednisolone | 1 | 1979 | 324 | 0.010 |
Why?
|
Organ Specificity | 1 | 1983 | 1963 | 0.010 |
Why?
|
Diarrhea | 1 | 1985 | 1316 | 0.010 |
Why?
|
Benzamides | 1 | 2003 | 1371 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2005 | 1316 | 0.010 |
Why?
|
Hexamethonium | 2 | 1987 | 17 | 0.010 |
Why?
|
Life Style | 1 | 2009 | 3907 | 0.010 |
Why?
|
Portacaval Shunt, Surgical | 1 | 1977 | 46 | 0.010 |
Why?
|
Molecular Sequence Data | 3 | 1995 | 17598 | 0.010 |
Why?
|
Venae Cavae | 1 | 1977 | 40 | 0.010 |
Why?
|
Microvilli | 1 | 1978 | 234 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2004 | 1480 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2005 | 11067 | 0.010 |
Why?
|
Pan troglodytes | 1 | 1978 | 223 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2004 | 1067 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2004 | 3461 | 0.010 |
Why?
|
Fibrinolysis | 1 | 1978 | 332 | 0.010 |
Why?
|
Appendicitis | 1 | 2004 | 676 | 0.010 |
Why?
|
Blood Vessels | 1 | 1983 | 1111 | 0.010 |
Why?
|
Pulmonary Circulation | 2 | 1977 | 737 | 0.010 |
Why?
|
Diphenhydramine | 1 | 1977 | 63 | 0.010 |
Why?
|
Pyruvates | 1 | 1977 | 83 | 0.010 |
Why?
|
Carbohydrates | 1 | 1999 | 389 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 3307 | 0.010 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 1996 | 23 | 0.010 |
Why?
|
Critical Illness | 1 | 2009 | 2724 | 0.010 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1997 | 179 | 0.010 |
Why?
|
Spleen | 1 | 1983 | 2290 | 0.010 |
Why?
|
Plasma Substitutes | 1 | 1996 | 57 | 0.010 |
Why?
|
Penicillamine | 1 | 1996 | 60 | 0.010 |
Why?
|
Synaptic Transmission | 2 | 1994 | 1167 | 0.010 |
Why?
|
Devazepide | 1 | 1996 | 4 | 0.010 |
Why?
|
Receptors, Cholecystokinin | 1 | 1996 | 18 | 0.010 |
Why?
|
Cisterna Magna | 1 | 1996 | 39 | 0.010 |
Why?
|
Marfan Syndrome | 1 | 1978 | 236 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1980 | 1056 | 0.010 |
Why?
|
Benzodiazepinones | 1 | 1996 | 50 | 0.010 |
Why?
|
Buffers | 1 | 1996 | 143 | 0.010 |
Why?
|
Piperidines | 1 | 1985 | 1656 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2006 | 2820 | 0.010 |
Why?
|
Bradykinin | 1 | 1996 | 205 | 0.010 |
Why?
|
Leg | 1 | 1981 | 1087 | 0.010 |
Why?
|
Resuscitation | 2 | 1978 | 672 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5493 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1982 | 1611 | 0.010 |
Why?
|
Lactates | 1 | 1977 | 401 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10553 | 0.010 |
Why?
|
Cecum | 1 | 1996 | 233 | 0.010 |
Why?
|
Blood Preservation | 1 | 1976 | 169 | 0.010 |
Why?
|
Potentiometry | 1 | 1975 | 10 | 0.010 |
Why?
|
Receptors, Cholinergic | 2 | 1987 | 244 | 0.010 |
Why?
|
NF-kappa B | 1 | 2004 | 2475 | 0.010 |
Why?
|
Hormone Antagonists | 1 | 1996 | 107 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5748 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1975 | 181 | 0.010 |
Why?
|
Ligation | 1 | 1996 | 446 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2000 | 1695 | 0.010 |
Why?
|
Ion Exchange | 1 | 1975 | 16 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1995 | 6067 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1996 | 11733 | 0.010 |
Why?
|
Double-Blind Method | 1 | 1989 | 12341 | 0.010 |
Why?
|
Sympatholytics | 1 | 1975 | 82 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1240 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4921 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2004 | 2881 | 0.010 |
Why?
|
Cyclic GMP | 1 | 1996 | 395 | 0.010 |
Why?
|
Blood Volume | 1 | 1996 | 547 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11476 | 0.010 |
Why?
|
Aortic Diseases | 1 | 1980 | 735 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1996 | 561 | 0.010 |
Why?
|
Angiography | 2 | 1981 | 1597 | 0.010 |
Why?
|
Klebsiella Infections | 1 | 1976 | 144 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1995 | 775 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6504 | 0.010 |
Why?
|
Hydrocortisone | 1 | 1982 | 1818 | 0.010 |
Why?
|
Collateral Circulation | 1 | 1975 | 293 | 0.010 |
Why?
|
Portal Vein | 1 | 1977 | 432 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 1977 | 651 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2270 | 0.010 |
Why?
|
Ribonucleases | 1 | 1995 | 264 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2636 | 0.010 |
Why?
|
Bicarbonates | 1 | 1975 | 292 | 0.010 |
Why?
|
Administration, Topical | 1 | 1996 | 703 | 0.010 |
Why?
|
Models, Animal | 1 | 2000 | 2115 | 0.010 |
Why?
|
Gastroparesis | 1 | 1996 | 138 | 0.010 |
Why?
|
Enterobacteriaceae Infections | 1 | 1976 | 187 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 1995 | 223 | 0.010 |
Why?
|
RNA | 1 | 2003 | 2709 | 0.010 |
Why?
|
Radiology, Interventional | 1 | 1998 | 477 | 0.010 |
Why?
|
Computer Simulation | 1 | 2007 | 6224 | 0.010 |
Why?
|
Platelet Transfusion | 1 | 1996 | 298 | 0.010 |
Why?
|
Age Factors | 2 | 2005 | 18384 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1996 | 582 | 0.010 |
Why?
|
Palliative Care | 2 | 2004 | 3599 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1995 | 1301 | 0.010 |
Why?
|
Algorithms | 3 | 2003 | 14025 | 0.010 |
Why?
|
Molecular Probes | 1 | 1995 | 309 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1976 | 1088 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2522 | 0.010 |
Why?
|
Neural Pathways | 2 | 1996 | 3056 | 0.010 |
Why?
|
Serum Albumin | 1 | 1996 | 674 | 0.010 |
Why?
|
Plasma | 1 | 1996 | 586 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1989 | 14610 | 0.010 |
Why?
|
Choledochostomy | 1 | 1992 | 16 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5773 | 0.010 |
Why?
|
Needles | 1 | 1976 | 453 | 0.010 |
Why?
|
Bile Acids and Salts | 1 | 1975 | 394 | 0.010 |
Why?
|
Glucagon | 1 | 1995 | 531 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3446 | 0.010 |
Why?
|
Hospitals, County | 1 | 1992 | 17 | 0.010 |
Why?
|
Adenoma | 1 | 2003 | 2159 | 0.010 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 1992 | 86 | 0.010 |
Why?
|
Colic | 1 | 1992 | 44 | 0.010 |
Why?
|
Peptide Fragments | 2 | 1997 | 5103 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 1976 | 655 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1998 | 1664 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2005 | 3253 | 0.010 |
Why?
|
Hospitals, Private | 1 | 1992 | 63 | 0.010 |
Why?
|
Swine, Miniature | 1 | 1994 | 961 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2003 | 9278 | 0.010 |
Why?
|
Hospital Costs | 1 | 1998 | 947 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 1996 | 12474 | 0.010 |
Why?
|
Automation | 1 | 1994 | 585 | 0.010 |
Why?
|
Ethanolamines | 1 | 1992 | 153 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 1996 | 569 | 0.010 |
Why?
|
Pulmonary Artery | 2 | 1977 | 1929 | 0.010 |
Why?
|
Biliary Tract Diseases | 1 | 1992 | 158 | 0.010 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 1992 | 297 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1996 | 1784 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 1995 | 8519 | 0.010 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 1990 | 56 | 0.010 |
Why?
|
Enteric Nervous System | 1 | 1994 | 213 | 0.010 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1990 | 40 | 0.010 |
Why?
|
Shock, Septic | 1 | 1977 | 769 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1976 | 1156 | 0.010 |
Why?
|
Aorta | 1 | 1978 | 2040 | 0.010 |
Why?
|
Somatostatinoma | 1 | 1990 | 11 | 0.010 |
Why?
|
Glucagonoma | 1 | 1990 | 14 | 0.010 |
Why?
|
Bupivacaine | 1 | 1994 | 411 | 0.010 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1994 | 668 | 0.010 |
Why?
|
Swine | 2 | 1994 | 5909 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1992 | 584 | 0.010 |
Why?
|
Length of Stay | 2 | 1995 | 6417 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7865 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9416 | 0.010 |
Why?
|
Leiomyosarcoma | 1 | 1994 | 422 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1978 | 1463 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1975 | 1241 | 0.010 |
Why?
|
Axilla | 1 | 1992 | 624 | 0.010 |
Why?
|
Body Weight | 1 | 2000 | 4618 | 0.010 |
Why?
|
Insulinoma | 1 | 1990 | 121 | 0.010 |
Why?
|
Stents | 2 | 1992 | 3177 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1994 | 2112 | 0.000 |
Why?
|
Hypotension | 1 | 1975 | 879 | 0.000 |
Why?
|
Fibrinolytic Agents | 1 | 1978 | 2075 | 0.000 |
Why?
|
Ethanol | 1 | 1975 | 1322 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1975 | 1867 | 0.000 |
Why?
|
Silicone Elastomers | 1 | 1988 | 78 | 0.000 |
Why?
|
Aortic Valve | 1 | 1978 | 1959 | 0.000 |
Why?
|
Coenzyme A | 1 | 1968 | 39 | 0.000 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1996 | 3512 | 0.000 |
Why?
|
Sclerosis | 1 | 1988 | 210 | 0.000 |
Why?
|
Nitrogen | 1 | 1989 | 345 | 0.000 |
Why?
|
Cell-Free System | 1 | 1968 | 336 | 0.000 |
Why?
|
Receptors, Adrenergic | 1 | 1987 | 155 | 0.000 |
Why?
|
Vagotomy | 1 | 1986 | 83 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9566 | 0.000 |
Why?
|
Dilatation | 1 | 1988 | 307 | 0.000 |
Why?
|
Gastrointestinal Contents | 1 | 1986 | 42 | 0.000 |
Why?
|
Ligases | 1 | 1968 | 333 | 0.000 |
Why?
|
Linear Models | 1 | 1996 | 5869 | 0.000 |
Why?
|
Histamine H1 Antagonists | 1 | 1986 | 101 | 0.000 |
Why?
|
Cerebrovascular Circulation | 1 | 1976 | 2725 | 0.000 |
Why?
|
Alcoholism | 2 | 1990 | 1973 | 0.000 |
Why?
|
Fat Emulsions, Intravenous | 1 | 1989 | 314 | 0.000 |
Why?
|
Acyltransferases | 1 | 1968 | 304 | 0.000 |
Why?
|
Aortic Valve Stenosis | 1 | 1978 | 2018 | 0.000 |
Why?
|
Motilin | 1 | 1985 | 3 | 0.000 |
Why?
|
Ketanserin | 1 | 1985 | 24 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1994 | 4822 | 0.000 |
Why?
|
Histamine H2 Antagonists | 1 | 1986 | 166 | 0.000 |
Why?
|
Nerve Endings | 1 | 1985 | 105 | 0.000 |
Why?
|
Anesthetics, Local | 1 | 1992 | 998 | 0.000 |
Why?
|
Carbachol | 1 | 1985 | 223 | 0.000 |
Why?
|
Vasomotor System | 1 | 1985 | 208 | 0.000 |
Why?
|
Remission Induction | 1 | 1990 | 2392 | 0.000 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1992 | 2024 | 0.000 |
Why?
|
Graft Survival | 1 | 1994 | 3843 | 0.000 |
Why?
|
Histamine | 1 | 1985 | 499 | 0.000 |
Why?
|
Radionuclide Imaging | 2 | 1977 | 1989 | 0.000 |
Why?
|
Cholangiography | 1 | 1983 | 181 | 0.000 |
Why?
|
Dietary Proteins | 1 | 1987 | 951 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1968 | 1988 | 0.000 |
Why?
|
Mammography | 1 | 1992 | 2430 | 0.000 |
Why?
|
Ascites | 1 | 1983 | 338 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7571 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1985 | 2468 | 0.000 |
Why?
|
Retroperitoneal Space | 1 | 1980 | 170 | 0.000 |
Why?
|
Wakefulness | 1 | 1987 | 1264 | 0.000 |
Why?
|
Aneurysm | 1 | 1983 | 337 | 0.000 |
Why?
|
Adrenalectomy | 1 | 1981 | 346 | 0.000 |
Why?
|
Intraoperative Care | 1 | 1983 | 767 | 0.000 |
Why?
|
Receptors, Histamine H2 | 1 | 1978 | 18 | 0.000 |
Why?
|
Receptors, Histamine H1 | 1 | 1978 | 19 | 0.000 |
Why?
|
Plasminogen Inactivators | 1 | 1978 | 37 | 0.000 |
Why?
|
Plasminogen Activators | 1 | 1978 | 199 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1980 | 625 | 0.000 |
Why?
|
Streptokinase | 1 | 1977 | 186 | 0.000 |
Why?
|
Alkalosis, Respiratory | 1 | 1976 | 20 | 0.000 |
Why?
|
Acidosis, Respiratory | 1 | 1976 | 37 | 0.000 |
Why?
|
Radioactive Tracers | 1 | 1976 | 68 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1994 | 11509 | 0.000 |
Why?
|
Blood Transfusion, Autologous | 1 | 1976 | 130 | 0.000 |
Why?
|
Aortic Aneurysm | 1 | 1980 | 648 | 0.000 |
Why?
|
Blood Vessel Prosthesis | 1 | 1980 | 951 | 0.000 |
Why?
|
Electromagnetic Phenomena | 1 | 1976 | 160 | 0.000 |
Why?
|
Blood Gas Analysis | 1 | 1976 | 379 | 0.000 |
Why?
|
Carotid Artery, Internal | 1 | 1976 | 445 | 0.000 |
Why?
|
Hot Temperature | 1 | 1977 | 1434 | 0.000 |
Why?
|
Brain | 1 | 1996 | 27092 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1980 | 26199 | 0.000 |
Why?
|
Infant | 1 | 1980 | 36169 | 0.000 |
Why?
|
Lung | 1 | 1977 | 9979 | 0.000 |
Why?
|
Child, Preschool | 1 | 1980 | 42224 | 0.000 |
Why?
|
Child | 1 | 1980 | 80152 | 0.000 |
Why?
|